{"id":31332,"date":"2020-04-20T06:36:00","date_gmt":"2020-04-20T01:06:00","guid":{"rendered":"https:\/\/johnsonfrancis.org\/professional\/?p=31332"},"modified":"2020-04-20T06:36:00","modified_gmt":"2020-04-20T01:06:00","slug":"drug-challenge-in-brugada-syndrome-cardiology-mcq-answer","status":"publish","type":"post","link":"https:\/\/johnsonfrancis.org\/professional\/drug-challenge-in-brugada-syndrome-cardiology-mcq-answer\/","title":{"rendered":"Drug challenge in Brugada syndrome &#8211; Cardiology MCQ &#8211; Answer"},"content":{"rendered":"<p><iframe loading=\"lazy\" width=\"560\" height=\"315\" src=\"https:\/\/www.youtube.com\/embed\/Hj4KaYDK_oE\" title=\"YouTube video player\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture\" allowfullscreen=\"\"><\/iframe><\/p>\n<h2><span style=\"color: #008000;\">Drug challenge in Brugada syndrome &#8211; Cardiology MCQ &#8211; Answer<\/span><\/h2>\n<p><span style=\"color: #0000ff;\"><strong>Which of the following is not usually used as drug challenge to unmask the Brugada Type I ECG pattern? &#8211; Correct answer: <\/strong><\/span><strong><span style=\"font-size: inherit; color: #0000ff;\">d) Propranolol<\/span><\/strong><\/p>\n<p>Drug challenge is used when there is clinical suspicion in the form of syncope, agonal respiration and family history, but ECG does not show the classical type I Brugada syndrome ECG. Sodium channel blockers are used to unmask the ECG changes of the disease. Drug challenge should be cautiously done with continuous ECG monitoring and occurrence of QRS widening more than 130% of baseline, frequent ventricular ectopics or complex ventricular ectopy mandate discontinuation of drug infusion to prevent life threatening ventricular arrhythmias [1]. In case of prolonged cardiac arrest, advanced cardiopulmonary resuscitation (ECPR) with extra corporeal membrane oxygenator (ECMO) may be needed in refractory cases [2].<\/p>\n<p>Intravenous ajmaline or flecainide can be used for the drug challenge in Brugada syndrome. Alternative drug is procainamide. Oral flecainide or propafenone are used when intravenous Class I anti arrhythmic agents are not available [1].<\/p>\n<p><a href=\"https:\/\/johnsonfrancis.org\/professional\/drug-challenge-in-brugada-syndrome-cardiology-mcq\/\"><strong>Back to question<\/strong><\/a><\/p>\n<p><strong><span style=\"color: #0000ff;\">References<\/span><\/strong><\/p>\n<ol>\n<li>Brugada J, Campuzano O, Arbelo E, Sarquella-Brugada G, Brugada R. Present Status of Brugada Syndrome: JACC State-of-the-Art Review. J Am Coll Cardiol. 2018 Aug 28;72(9):1046-1059.<\/li>\n<li>Poli S, Toniolo M, Maiani M, Zanuttini D, Rebellato L, Vendramin I, Dametto E, Bernardi G, Bassi F, Napolitano C, Livi U, Proclemer A. <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28521022\">Management of untreatable ventricular arrhythmias during pharmacologic challenges with sodium channel blockers for suspected Brugada syndrome<\/a>. Europace. 2018 Feb 1;20(2):234-242.<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"<p>Drug challenge in Brugada syndrome &#8211; Cardiology MCQ &#8211; Answer Which of the following is not usually used as drug challenge to unmask the Brugada Type I ECG pattern? &#8211; Correct answer: d) Propranolol Drug challenge is used when there is clinical suspicion in the form of syncope, agonal respiration and family history, but ECG [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":30984,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"nf_dc_page":"","footnotes":""},"categories":[3,5],"tags":[],"class_list":["post-31332","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cardiology-mcq","category-dm-dnb-cardiology-entrance"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Drug challenge in Brugada syndrome - Cardiology MCQ - Answer - All About Cardiovascular System and Disorders<\/title>\n<meta name=\"description\" content=\"Drug challenge in Brugada syndrome is usually done when there is clinical suspicion, but baseline ECG is not type I. Sodium channel blocking drugs are used.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/johnsonfrancis.org\/professional\/drug-challenge-in-brugada-syndrome-cardiology-mcq-answer\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Drug challenge in Brugada syndrome - Cardiology MCQ - Answer - All About Cardiovascular System and Disorders\" \/>\n<meta property=\"og:description\" content=\"Drug challenge in Brugada syndrome is usually done when there is clinical suspicion, but baseline ECG is not type I. Sodium channel blocking drugs are used.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/johnsonfrancis.org\/professional\/drug-challenge-in-brugada-syndrome-cardiology-mcq-answer\/\" \/>\n<meta property=\"og:site_name\" content=\"All About Cardiovascular System and Disorders\" \/>\n<meta property=\"article:published_time\" content=\"2020-04-20T01:06:00+00:00\" \/>\n<meta name=\"author\" content=\"Johnson Francis\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Johnson Francis\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/drug-challenge-in-brugada-syndrome-cardiology-mcq-answer\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/drug-challenge-in-brugada-syndrome-cardiology-mcq-answer\\\/\"},\"author\":{\"name\":\"Johnson Francis\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"headline\":\"Drug challenge in Brugada syndrome &#8211; Cardiology MCQ &#8211; Answer\",\"datePublished\":\"2020-04-20T01:06:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/drug-challenge-in-brugada-syndrome-cardiology-mcq-answer\\\/\"},\"wordCount\":252,\"publisher\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"image\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/drug-challenge-in-brugada-syndrome-cardiology-mcq-answer\\\/#primaryimage\"},\"thumbnailUrl\":\"\",\"articleSection\":[\"Cardiology MCQ\",\"DM \\\/ DNB Cardiology Entrance\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/drug-challenge-in-brugada-syndrome-cardiology-mcq-answer\\\/\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/drug-challenge-in-brugada-syndrome-cardiology-mcq-answer\\\/\",\"name\":\"Drug challenge in Brugada syndrome - Cardiology MCQ - Answer - All About Cardiovascular System and Disorders\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/drug-challenge-in-brugada-syndrome-cardiology-mcq-answer\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/drug-challenge-in-brugada-syndrome-cardiology-mcq-answer\\\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2020-04-20T01:06:00+00:00\",\"description\":\"Drug challenge in Brugada syndrome is usually done when there is clinical suspicion, but baseline ECG is not type I. Sodium channel blocking drugs are used.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/drug-challenge-in-brugada-syndrome-cardiology-mcq-answer\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/drug-challenge-in-brugada-syndrome-cardiology-mcq-answer\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/drug-challenge-in-brugada-syndrome-cardiology-mcq-answer\\\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/drug-challenge-in-brugada-syndrome-cardiology-mcq-answer\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Drug challenge in Brugada syndrome &#8211; Cardiology MCQ &#8211; Answer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#website\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/\",\"name\":\"All About Cardiovascular System and Disorders\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":[\"Person\",\"Organization\"],\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\",\"name\":\"Johnson Francis\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"caption\":\"Johnson Francis\"},\"logo\":{\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\"},\"description\":\"Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/author\\\/jf\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Drug challenge in Brugada syndrome - Cardiology MCQ - Answer - All About Cardiovascular System and Disorders","description":"Drug challenge in Brugada syndrome is usually done when there is clinical suspicion, but baseline ECG is not type I. Sodium channel blocking drugs are used.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/johnsonfrancis.org\/professional\/drug-challenge-in-brugada-syndrome-cardiology-mcq-answer\/","og_locale":"en_US","og_type":"article","og_title":"Drug challenge in Brugada syndrome - Cardiology MCQ - Answer - All About Cardiovascular System and Disorders","og_description":"Drug challenge in Brugada syndrome is usually done when there is clinical suspicion, but baseline ECG is not type I. Sodium channel blocking drugs are used.","og_url":"https:\/\/johnsonfrancis.org\/professional\/drug-challenge-in-brugada-syndrome-cardiology-mcq-answer\/","og_site_name":"All About Cardiovascular System and Disorders","article_published_time":"2020-04-20T01:06:00+00:00","author":"Johnson Francis","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Johnson Francis","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/johnsonfrancis.org\/professional\/drug-challenge-in-brugada-syndrome-cardiology-mcq-answer\/#article","isPartOf":{"@id":"https:\/\/johnsonfrancis.org\/professional\/drug-challenge-in-brugada-syndrome-cardiology-mcq-answer\/"},"author":{"name":"Johnson Francis","@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"headline":"Drug challenge in Brugada syndrome &#8211; Cardiology MCQ &#8211; Answer","datePublished":"2020-04-20T01:06:00+00:00","mainEntityOfPage":{"@id":"https:\/\/johnsonfrancis.org\/professional\/drug-challenge-in-brugada-syndrome-cardiology-mcq-answer\/"},"wordCount":252,"publisher":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"image":{"@id":"https:\/\/johnsonfrancis.org\/professional\/drug-challenge-in-brugada-syndrome-cardiology-mcq-answer\/#primaryimage"},"thumbnailUrl":"","articleSection":["Cardiology MCQ","DM \/ DNB Cardiology Entrance"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/johnsonfrancis.org\/professional\/drug-challenge-in-brugada-syndrome-cardiology-mcq-answer\/","url":"https:\/\/johnsonfrancis.org\/professional\/drug-challenge-in-brugada-syndrome-cardiology-mcq-answer\/","name":"Drug challenge in Brugada syndrome - Cardiology MCQ - Answer - All About Cardiovascular System and Disorders","isPartOf":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#website"},"primaryImageOfPage":{"@id":"https:\/\/johnsonfrancis.org\/professional\/drug-challenge-in-brugada-syndrome-cardiology-mcq-answer\/#primaryimage"},"image":{"@id":"https:\/\/johnsonfrancis.org\/professional\/drug-challenge-in-brugada-syndrome-cardiology-mcq-answer\/#primaryimage"},"thumbnailUrl":"","datePublished":"2020-04-20T01:06:00+00:00","description":"Drug challenge in Brugada syndrome is usually done when there is clinical suspicion, but baseline ECG is not type I. Sodium channel blocking drugs are used.","breadcrumb":{"@id":"https:\/\/johnsonfrancis.org\/professional\/drug-challenge-in-brugada-syndrome-cardiology-mcq-answer\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/johnsonfrancis.org\/professional\/drug-challenge-in-brugada-syndrome-cardiology-mcq-answer\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/johnsonfrancis.org\/professional\/drug-challenge-in-brugada-syndrome-cardiology-mcq-answer\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/johnsonfrancis.org\/professional\/drug-challenge-in-brugada-syndrome-cardiology-mcq-answer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/johnsonfrancis.org\/professional\/"},{"@type":"ListItem","position":2,"name":"Drug challenge in Brugada syndrome &#8211; Cardiology MCQ &#8211; Answer"}]},{"@type":"WebSite","@id":"https:\/\/johnsonfrancis.org\/professional\/#website","url":"https:\/\/johnsonfrancis.org\/professional\/","name":"All About Cardiovascular System and Disorders","description":"","publisher":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/johnsonfrancis.org\/professional\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":["Person","Organization"],"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec","name":"Johnson Francis","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","caption":"Johnson Francis"},"logo":{"@id":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g"},"description":"Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal","url":"https:\/\/johnsonfrancis.org\/professional\/author\/jf\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/31332","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/comments?post=31332"}],"version-history":[{"count":0,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/31332\/revisions"}],"wp:attachment":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/media?parent=31332"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/categories?post=31332"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/tags?post=31332"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}